Astera Labs (NASDAQ:ALAB) Stock Jumps 4.6% - Still a Buy?

Astera Labs logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Astera Labs shares rose 4.6% to $211.60 in Tuesday trading, on volume slightly below its daily average.
  • The company beat quarterly estimates, reporting EPS of $1.32 versus $1.19 expected and revenue of $584.9 million, up 153.6% year over year. Its expanded collaboration with Hyve Solutions also highlights demand for its AI-infrastructure products.
  • Analysts rate the stock a consensus Moderate Buy, with an average price target of $320.85, though recent target cuts and comparisons citing Astera’s high valuation point to risks.
  • MarketBeat previews the top five stocks to own by December 1st.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report)'s share price rose 4.6% on Tuesday. The stock traded as high as $212.03 and last traded at $211.60. Approximately 4,967,965 shares were traded during mid-day trading, a decline of 3% from the average daily volume of 5,137,946 shares. The stock had previously closed at $202.34.

Latest Astera Labs News

These are some of the ALAB news items that stood out recently:

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the company. Roth Capital reissued a "buy" rating and set a $450.00 price target on shares of Astera Labs in a research report on Wednesday, August 5th. Royal Bank Of Canada cut their target price on Astera Labs from $500.00 to $400.00 and set an "outperform" rating for the company in a research report on Wednesday, November 4th. Morgan Stanley increased their target price on Astera Labs from $382.00 to $389.00 and gave the stock an "overweight" rating in a report on Wednesday, November 4th. Barclays raised their price target on Astera Labs from $200.00 to $325.00 and gave the stock an "equal weight" rating in a research report on Monday, July 20th. Finally, Citigroup downgraded Astera Labs from a "buy" rating to a "hold" rating in a research note on Friday, October 9th. Thirteen research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. Based on data from MarketBeat, Astera Labs has a consensus rating of "Moderate Buy" and an average target price of $320.85.

View Our Latest Stock Report on ALAB

Astera Labs Stock Performance

The company has a market capitalization of $36.98 billion, a P/E ratio of 84.30 and a beta of 3.85. The stock's 50 day moving average price is $292.10 and its 200 day moving average price is $257.26.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings data on Tuesday, November 3rd. The company reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.13. Astera Labs had a net margin of 29.64% and a return on equity of 25.35%. The company had revenue of $584.90 million during the quarter, compared to analyst estimates of $550.78 million. During the same quarter in the previous year, the business posted $0.49 EPS. Astera Labs's revenue for the quarter was up 153.6% compared to the same quarter last year. On average, analysts expect that Astera Labs, Inc. will post 2.99 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Manuel Alba sold 183,000 shares of the business's stock in a transaction that occurred on Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total value of $51,263,790.00. Following the transaction, the director owned 253,863 shares in the company, valued at $71,114,642.19. The trade was a 41.89% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan Dyckerhoff sold 8,994 shares of the business's stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $274.96, for a total value of $2,472,990.24. Following the completion of the transaction, the director directly owned 3,309 shares in the company, valued at approximately $909,842.64. This represents a 73.10% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 220,497 shares of company stock worth $62,043,303. 10.40% of the stock is owned by corporate insiders.

Institutional Trading of Astera Labs

Hedge funds and other institutional investors have recently modified their holdings of the business. Amazon Com Inc. acquired a new position in Astera Labs during the second quarter valued at $134,172,000. Edgestream Partners L.P. acquired a new position in shares of Astera Labs during the 1st quarter worth approximately $1,891,000. Sanders Morris Harris LLC purchased a new position in Astera Labs during the third quarter valued at $4,821,000. Lido Advisors LLC lifted its stake in Astera Labs by 123.4% in the 1st quarter. Lido Advisors LLC now owns 27,477 shares of the company's stock valued at $3,012,000 after buying an additional 15,180 shares in the last quarter. Finally, Silvant Capital Management LLC purchased a new stake in shares of Astera Labs during the second quarter worth approximately $11,277,000. Institutional investors own 60.47% of the company's stock.

Astera Labs Company Profile

(Get Free Report)

Astera Labs, Inc. is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems. The company's portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Astera Labs Right Now?

Before you consider Astera Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.

While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines